| 000 | 00923 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517102814.0 | ||
| 264 | 0 | _c20160721 | |
| 008 | 201607s 0 0 jpn d | ||
| 022 | _a0385-0684 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUsui, Noriko | |
| 245 | 0 | 0 |
_a[Hematologic Malignancies/Pediatric Malignancies. Roles of Drugs Approved as New Agents and as Additional Indications for Relapse or Refractory Hematologic Malignancies]. _h[electronic resource] |
| 260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cMay 2016 |
||
| 300 |
_a528-9 p. _bdigital |
||
| 500 | _aPublication Type: Introductory Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRecurrence |
| 773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 43 _gno. 5 _gp. 528-9 |
|
| 999 |
_c26161574 _d26161574 |
||